
5.52BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US6047491013
CUSIP
604749101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.16
Dividend Share
-
Dividend Yield
-
Earnings Share
-14.24
Wall Street Target Price
153.43
EPS Estimate Current Year
-15.23
EPS Estimate Next Year
-0.71
EPS Estimate Current Quarter
-0.746
EPS Estimate Next Quarter
-0.686
Most Recent Quarter
-
Revenue TTM
618,067,008
Gross Profit TTM
505,112,992
EBITDA
-70,283,000
Profit Margin
-139.18%
Return On Assets TTM
-6.79%
Return On Equity TTM
-702.97%
Revenue Per Share TTM
11.016
Qtly Revenue Growth YOY
37.90%
Diluted Eps TTM
-14.24
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
175
Price Sales TTM
9.0076
Price Book MRQ
26.591
Enterprise Value Revenue
9
Enterprise Value EBITDA
341
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%